Ruscio, E.; Scacciavillani, R.; Gurgoglione, F.L.; Pinnacchio, G.; Bencardino, G.; Perna, F.; Narducci, M.L.; Pelargonio, G.; Niccoli, G.; Locorotondo, G.;
et al. Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions. Biomedicines 2025, 13, 2626.
https://doi.org/10.3390/biomedicines13112626
AMA Style
Ruscio E, Scacciavillani R, Gurgoglione FL, Pinnacchio G, Bencardino G, Perna F, Narducci ML, Pelargonio G, Niccoli G, Locorotondo G,
et al. Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions. Biomedicines. 2025; 13(11):2626.
https://doi.org/10.3390/biomedicines13112626
Chicago/Turabian Style
Ruscio, Eleonora, Roberto Scacciavillani, Filippo Luca Gurgoglione, Gaetano Pinnacchio, Gianluigi Bencardino, Francesco Perna, Maria Lucia Narducci, Gemma Pelargonio, Giampaolo Niccoli, Gabriella Locorotondo,
and et al. 2025. "Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions" Biomedicines 13, no. 11: 2626.
https://doi.org/10.3390/biomedicines13112626
APA Style
Ruscio, E., Scacciavillani, R., Gurgoglione, F. L., Pinnacchio, G., Bencardino, G., Perna, F., Narducci, M. L., Pelargonio, G., Niccoli, G., Locorotondo, G., & Burzotta, F.
(2025). Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions. Biomedicines, 13(11), 2626.
https://doi.org/10.3390/biomedicines13112626
